Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1980 Feb;65(2):514–518. doi: 10.1172/JCI109695

Endogenous pyrogen production by Hodgkin's disease and human histiocytic lymphoma cell lines in vitro.

P Bodel, P Ralph, K Wenc, J C Long
PMCID: PMC371390  PMID: 6985918

Abstract

Fever not explained by infection may occur in patients with malignant lymphoma presumably caused by a release of endogenous pyrogen. Although pyrogen has been found in some tumors with a mixed cell population, production of endogenous pyrogen by the neoplastic cells has not been demonstrated. This report documents the apparently spontaneous synthesis and release of such pyrogen by two human tumor cell lines derived from patients with Hodgkin's disease and histiocytic lymphoma. The endogenous pyrogen from the two cell lines was similar and closely resembled that produced by normal human monocytes in antigenic properties as well as heat and pronase sensitivity. The Hodgkin's disease and histiocytic lymphoma cell lines do not require specific stimulation for the production of endogenous pyrogen suggesting that the mechanism of pyrogen release by neoplastic macrophage-related cells differs from that of normal phagocytic cells. The tumor-associated fever in some patients with malignant lymphoma may be caused by a release of endogenous pyrogen by proliferating neoplastic cells.

Full text

PDF
514

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkins E., Bodel P. Clinical fever: its history, manifestations and pathogenesis. Fed Proc. 1979 Jan;38(1):57–63. [PubMed] [Google Scholar]
  2. Bodel P. Generalized perturbations in host physiology caused by localized tumors. Tumors and fever. Ann N Y Acad Sci. 1974;230:6–13. doi: 10.1111/j.1749-6632.1974.tb14434.x. [DOI] [PubMed] [Google Scholar]
  3. Bodel P., Miller H. A new sensitive method for detecting human endogenous (leukocyte) pyrogen. Inflammation. 1978 Mar;3(1):103–110. doi: 10.1007/BF00917325. [DOI] [PubMed] [Google Scholar]
  4. Bodel P., Miller H. Differences in pyrogen production by mononuclear phagocytes and by fibroblasts or HeLa cells. J Exp Med. 1977 Mar 1;145(3):607–617. doi: 10.1084/jem.145.3.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bodel P., Miller H. Pyrogen from mouse macrophages causes fever in mice. Proc Soc Exp Biol Med. 1976 Jan;151(1):93–96. doi: 10.3181/00379727-151-39150. [DOI] [PubMed] [Google Scholar]
  6. Bodel P. Pyrogen release in vitro by lymphoid tissues from patients with Hodgkin's disease. Yale J Biol Med. 1974;47(2):101–112. [PMC free article] [PubMed] [Google Scholar]
  7. Bodel P. Spontaneous pyrogen production by mouse histiocytic and myelomonocytic tumor cell lines in vitro. J Exp Med. 1978 May 1;147(5):1503–15l6. [PMC free article] [PubMed] [Google Scholar]
  8. Dinarello C. A., Goldin N. P., Wolff S. M. Demonstration and characterization of two distinct human leukocytic pyrogens. J Exp Med. 1974 Jun 1;139(6):1369–1381. doi: 10.1084/jem.139.6.1369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dinarello C. A. Production of endogenous pyrogen. Fed Proc. 1979 Jan;38(1):52–56. [PubMed] [Google Scholar]
  10. Dinarello C. A., Renfer L., Wolff S. M. Human leukocytic pyrogen: purification and development of a radioimmunoassay. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4624–4627. doi: 10.1073/pnas.74.10.4624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dinarello C. A., Renfer L., Wolff S. M. The production of antibody against human leukocytic pyrogen. J Clin Invest. 1977 Aug;60(2):465–472. doi: 10.1172/JCI108797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dinarello C. A., Wolff S. M. Pathogenesis of fever in man. N Engl J Med. 1978 Mar 16;298(11):607–612. doi: 10.1056/NEJM197803162981107. [DOI] [PubMed] [Google Scholar]
  13. Gang D. L., Long J. C., Zamecnik P. C., Chi S. Y., Dvorak A. M. Electron microscopy of Hodgkin's disease tissue cultures. Cancer. 1979 Aug;44(2):543–557. doi: 10.1002/1097-0142(197908)44:2<543::aid-cncr2820440223>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  14. Haeseler F., Bodel P., Atkins E. Characteristics of pyrogen production by isolated rabbit Kupffer cells in vitro. J Reticuloendothel Soc. 1977 Dec;22(6):569–581. [PubMed] [Google Scholar]
  15. Jones S. E., Fuks Z., Bull M., Kadin M. E., Dorfman R. F., Kaplan H. S., Rosenberg S. A., Kim H. Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer. 1973 Apr;31(4):806–823. doi: 10.1002/1097-0142(197304)31:4<806::aid-cncr2820310408>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  16. Long J. C. The immunopathology of Hodgkin's disease. Clin Haematol. 1979 Oct;8(3):531–566. doi: 10.1016/s0308-2261(79)80003-x. [DOI] [PubMed] [Google Scholar]
  17. Long J. C., Zamecnik P. C., Aisenberg A. C., Atkins L. Tissue culture studies in Hodgkin's disease: Morphologic, cytogenetic, cell surface, and enzymatic properties of cultures derived from splenic tumors. J Exp Med. 1977 Jun 1;145(6):1484–1500. doi: 10.1084/jem.145.6.1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ralph P., Moore M. A., Nilsson K. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med. 1976 Jun 1;143(6):1528–1533. doi: 10.1084/jem.143.6.1528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rawlins M. D., Luff R. H., Cranston W. I. Pyrexia in renal carcinoma. Lancet. 1970 Jun 27;1(7661):1371–1373. doi: 10.1016/s0140-6736(70)91274-2. [DOI] [PubMed] [Google Scholar]
  20. Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 1976 May 15;17(5):565–577. doi: 10.1002/ijc.2910170504. [DOI] [PubMed] [Google Scholar]
  21. Zamecnik P. C., Long J. C. Growth of cultured cells from patients with Hodgkin's disease and transplantation into nude mice. Proc Natl Acad Sci U S A. 1977 Feb;74(2):754–758. doi: 10.1073/pnas.74.2.754. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES